DENTSPLY SIRONA (XRAY) – Analysts’ Weekly Ratings Changes

A number of firms have modified their ratings and price targets on shares of DENTSPLY SIRONA (NASDAQ: XRAY) recently:

• 8/10/2026 – DENTSPLY SIRONA was given a new $15.00 price target by Barrington Research.
• 8/7/2026 – DENTSPLY SIRONA had its “market perform” rating reaffirmed by BMO Capital Markets. They now have a $13.00 price target on the stock.
• 8/3/2026 – DENTSPLY SIRONA had its “sell (e+)” rating reaffirmed by Weiss Ratings.
• 7/29/2026 – DENTSPLY SIRONA had its price target raised by Piper Sandler from $13.00 to $14.00. They now have a “neutral” rating on the stock.
• 7/8/2026 – DENTSPLY SIRONA is now covered by BMO Capital Markets. They set a “market perform” rating and a $12.00 price target on the stock.
• 7/8/2026 – DENTSPLY SIRONA was upgraded by BMO Capital Markets to “hold”.

Insider Transactions at DENTSPLY SIRONA

In other DENTSPLY SIRONA news, Director Michael J. Barber purchased 15,175 shares of the firm’s stock in a transaction dated Thursday, June 11th. The stock was purchased at an average price of $9.88 per share, for a total transaction of $149,929.00. Following the completion of the purchase, the director directly owned 55,943 shares of the company’s stock, valued at $552,716.84. This trade represents a 37.22% increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Also, Director Brian T. Gladden purchased 9,985 shares of the stock in a transaction dated Monday, June 15th. The shares were acquired at an average cost of $10.02 per share, for a total transaction of $100,049.70. Following the completion of the acquisition, the director owned 61,849 shares of the company’s stock, valued at approximately $619,726.98. This represents a 19.25% increase in their ownership of the stock. The SEC filing for this purchase provides additional information. Insiders acquired 35,160 shares of company stock worth $351,179 over the last quarter. 0.46% of the stock is currently owned by insiders.

Dentsply Sirona Inc (NASDAQ: XRAY) is a leading global manufacturer of professional dental products and technologies. The company, formed through the merger of Dentsply International and Sirona Dental Systems in February 2016, brings together a long heritage of innovation in dental care. Headquartered in Charlotte, North Carolina, Dentsply Sirona develops and markets a comprehensive range of dental consumables, laboratory products, and advanced imaging and CAD/CAM systems.

The company’s product portfolio spans preventive, restorative, orthodontic, endodontic and surgical care.